Division of Microbiology and Immunology, Emory National Primate Research Center, Emory University, Atlanta, GA, USA.
Department of Infectious Disease Research, Southern Research, Frederick, MD, USA.
Sci Rep. 2023 Jul 6;13(1):10958. doi: 10.1038/s41598-023-37223-9.
The advent of combined antiretroviral therapy (cART) has been instrumental in controlling HIV-1 replication and transmission and decreasing associated morbidity and mortality. However, cART alone is not able to cure HIV-1 due to the presence of long-lived, latently infected immune cells, which re-seed plasma viremia when cART is interrupted. Assessment of HIV-cure strategies using ex vivo culture methods for further understanding of the diversity of reactivated HIV, viral outgrowth, and replication dynamics are enhanced using ultrasensitive digital ELISA based on single-molecule array (Simoa) technology to increase the sensitivity of endpoint detection. In viral outgrowth assays (VOA), exponential HIV-1 outgrowth has been shown to be dependent upon initial virus burst size surpassing a critical growth threshold of 5100 HIV-1 RNA copies. Here, we show an association between ultrasensitive HIV-1 Gag p24 concentrations and HIV-1 RNA copy number that characterize viral dynamics below the exponential replication threshold. Single-genome sequencing (SGS) revealed the presence of multiple identical HIV-1 sequences, indicative of low-level replication occurring below the threshold of exponential outgrowth early during a VOA. However, SGS further revealed diverse related HIV variants detectable by ultrasensitive methods that failed to establish exponential outgrowth. Overall, our data suggest that viral outgrowth occurring below the threshold necessary for establishing exponential growth in culture does not preclude replication competence of reactivated HIV, and ultrasensitive detection of HIV-1 p24 may provide a method to detect previously unquantifiable variants. These data strongly support the use of the Simoa platform in a multi-prong approach to measuring latent viral burden and efficacy of therapeutic interventions aimed at an HIV-1 cure.
联合抗逆转录病毒疗法(cART)的出现对于控制 HIV-1 的复制和传播以及降低相关发病率和死亡率起到了关键作用。然而,由于存在寿命长、潜伏感染的免疫细胞,cART 本身并不能治愈 HIV-1,当 cART 被中断时,这些细胞会重新引发血浆病毒血症。使用基于单分子阵列(Simoa)技术的超敏数字 ELISA 来评估 HIV 治愈策略,这种方法可以进一步了解重新激活的 HIV 的多样性、病毒生长和复制动力学,从而提高终点检测的灵敏度。在病毒生长实验(VOA)中,已经表明 HIV-1 的指数生长取决于初始病毒爆发量超过 5100 HIV-1 RNA 拷贝的临界生长阈值。在这里,我们展示了超敏 HIV-1 Gag p24 浓度与 HIV-1 RNA 拷贝数之间的关联,这些关联特征描述了指数复制阈值以下的病毒动力学。单基因组测序(SGS)揭示了存在多个相同的 HIV-1 序列,表明在 VOA 早期,低于指数生长阈值的低水平复制。然而,SGS 进一步揭示了超敏方法可检测到的多种相关 HIV 变体,但这些变体未能建立指数生长。总体而言,我们的数据表明,在培养中建立指数增长所需的阈值以下发生的病毒生长并不排除重新激活的 HIV 的复制能力,并且超敏检测 HIV-1 p24 可能提供一种方法来检测以前无法量化的变体。这些数据强烈支持在多方面方法中使用 Simoa 平台来测量潜伏病毒负荷和旨在治愈 HIV-1 的治疗干预措施的疗效。